
30-Capsule Trial
LDN 4.5 mg
- 30-day supply at one per day
- Lowest initial commitment
- Provider-directed use

A smarter conversation about inflammation and longevity.
Naltrexone HCl 4.5 mg compounded capsules
Starting this treatment? We’ll guide you through the health questions. Already approved? Choose your next quantity without starting over.
If you need new approval, we'll guide you through the questions before your order can ship.
01A real prescription—not another supplementLDN is a patient-specific compounded 4.5 mg capsule available only after a licensed provider reviews your health history, medications, and goals.
02Explore inflammatory balanceProposed effects involving brief opioid-receptor blockade, endorphin activity, and innate immune signaling are still being studied. Individual responses vary, and this does not establish an anti-aging benefit.
03Judge the routine by function over timeA consistent, multi-month evaluation gives you and your care team a clearer window to discuss recovery, resilience, and day-to-day function without promising a particular result.Pack duration assumes one capsule daily and may differ if your prescriber changes the schedule. No supply length guarantees an outcome.
“Longevity is not only about adding years—it is about feeling less worn down by the years you already have. LDN gives us a low-dose way to explore inflammatory balance and recovery without building another complicated routine, and having a pharmacist in your corner matters when it comes to timing, expectations, and knowing whether you are giving it a fair trial.”— Nathan Parker, MintRx Pharmacist
A PRACTICAL LONGEVITY CONVERSATION
Compounded medications are not FDA-approved; the FDA does not verify their safety, effectiveness, or quality before marketing. Do not use LDN while taking any opioid—it can precipitate severe withdrawal and block opioid pain treatment. Complete a private intake so a licensed provider can review your medications, health history, and goals.
Low Dose Naltrexone 4.5 mg capsules are compounded prescription medication and are not FDA-approved for any indication. Do not use while taking any opioid, including prescription pain medicines, tramadol, methadone, buprenorphine, fentanyl, or illicit opioids. Naltrexone can precipitate acute, potentially severe opioid withdrawal and can block opioid pain treatment. A prescriber must determine an adequate opioid-free interval; the vault notes at least 7–10 days may be required, but the appropriate interval varies by opioid and clinical context. Do not use with active opioid use disorder managed with agonist therapy, known naltrexone hypersensitivity, acute hepatitis, or hepatic failure. Disclose liver disease, abnormal liver tests, pregnancy, plans for pregnancy, and breastfeeding; use is generally avoided in pregnancy and nursing because safety data are limited. Common effects include vivid dreams, sleep disturbance, headache, nausea, constipation, and fatigue. Mood changes and liver injury are uncommon but require clinical attention. Seek urgent help for severe withdrawal, allergic reaction, severe abdominal pain, dark urine, or yellowing skin/eyes. Store at controlled room temperature and use before the pharmacy-labeled 180-day BUD. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent disease.